This page was last updated on 07/09/2020. Please check back frequently for updates.

Provider and Practice Information

ASCO has prepared a special report, A Guide to Cancer Care Delivery During the COVID-19 Pandemic. The report, developed with input from clinical experts, including ASCO’s Clinical Practice Committee, the COVID-19 Clinical Questions Advisory Group, and others, is intended to assist practices in developing their policies related to triage, screening, diagnostic testing, infection prevention and control, telemedicine, and other aspects of practice operations. This guide is available in eight languages: Arabic, Chinese (simplified), EnglishFrench, Japanese, Portuguese (Brazilian), Russian, and Spanish (Latin America).

COVID-19 Resources for Research Sites

The ASCO Research Community Forum has compiled resources to help support oncology researchers in dealing with the COVID-19 pandemic. This is a rapidly evolving situation and these resources will be updated on a regular basis. If you have a resource you would like to share, please e-mail ASCO Research Community Forum staff.

ASCO Webinars

The ASCO Global Webinar Series: Experiences and Lessons During the COVID-19 Pandemic is open for registration, with new events scheduled for June 30, July 28, August 25 and September 29.

Throughout April and May, ASCO hosted two webinar series to share important information and answer participant questions about the management of cancer and blood disorders during the COVID-19 pandemic. Recordings will remain available through June for those who would like to review a session.

  • Recordings from the ASCO-ONS Webinar Series: Caring for People with Cancer during COVID-19 Pandemic
  • Recordings from the ASCO Global Webinar Series: Experiences and Lessons During the COVID-19 Pandemic

ASCO/ACCC Webinar. ASCO also co-hosted a webinar with the Association of Community Cancer Centers on the ASCO Survey on COVID-19 in Oncology Registry (ASCO Registry). Recording

ASCO Guidance on Allocation of Scarce Resources During COVID-19 Pandemic

ASCO released new recommendations for the oncology community to consider as institutions across the country prepare to make difficult decisions about allocation of resources. The recommendations are not meant to be a guide for making individual allocation decisions.

The recommendations affirm the “inherent worth and dignity of each patient affected by cancer” and state that allocation decision processes “should not unconditionally deny patients with cancer consideration for access to scarce resources.”

Read the full recommendations published in the Journal of Clinical Oncology.

For a list of additional ethics resources, please view COVID-19 Ethics Resources for Oncologists.

Monitoring Drug Shortages During COVID-19 Pandemic

ASCO encourages its members to work together to ensure judicious use of any scarce resources. It is quite possible that we will experience drug shortages as this pandemic progresses, but there are resources available with reliable information. The FDA maintains a list of drugs in shortage, which includes information on expected duration of shortage and alternative suppliers, when available.

The FDA has requested that providers report any critical drug or biological products that may be in shortage or being closely monitored or rationed in your facility. Please include in your submission why the drug is considered critical in your practice. To report a shortage, visit How to Report a Product Shortage or Supply Issue to FDA.

Understanding the Impact of COVID-19 on Cancer Care

CancerLinQ and ASCO PracticeNET have compiled preliminary data on the impact of COVID-19 on various aspects of cancer care. Visit COVID-19 ASCO/CancerLinQ Data Insights for regular updates.

Articles from ASCO Journals to Assist Providers and Practices

Through the public health emergency, ASCO Journals will continue to expedite the publication of articles related to the COVID-19 pandemic.

The following articles have been accepted for publication after peer review and are available as preliminary versions.

Providing oncology pharmacy services during the coronavirus pandemic: French Society for Oncology Pharmacy (Société Francaise de Pharmacie Oncologique-SFPO) guidelines, Pourroy, et al, published in JCO Oncology Practice.

Oncology dietitians sound alarm in key nutrition needs of cancer patients during COVID-19 pandemic. Gibbs, et al, published in JCO Oncology Practice.

Recently published articles in ASCO Journals related to COVID-19 are available on the ASCO Publications site

Disclaimer

Answers to questions about COVID-19 published herein are provided by the American Society of Clinical Oncology, Inc. (“ASCO”) for voluntary, informational use by providers in the rapidly evolving novel coronavirus crisis. This information does not constitute medical or legal advice, is not intended for use in the diagnosis or treatment of individual conditions, does not endorse products or therapies, recommend or mandate any particular course of medical care, and is not a statement of the standard of care. New evidence may emerge between the time information is developed and when it is published or read. The information is not comprehensive or continually updated. This information is not intended to substitute for the independent professional judgment of the treating provider in the context of treating the individual patient. ASCO provides this information on an “as is” basis, and makes no warranty, express or implied, regarding the information. ASCO specifically disclaims any warranties of merchantability or fitness for a particular use or purpose. ASCO assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of this information or for any errors or omissions. Use of the information is subject to the complete ASCO website Terms of Use.